ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
사전등록 바로가기
 

  • P-ISSN1225-0163
  • E-ISSN2288-8985
  • SCOPUS, ESCI, KCI

논문 상세

Home > 논문 상세
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

논문 상세

    이전

    다음

    34권 5호
    PubReader Citation Share

    Method development and validation of spectrophotometric and RP-HPLC methods for simultaneous estimation of spironolactone and furosemide in bulk and combined tablet dosage forms

    분석과학 / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
    2021, v.34 no.5, pp.212-224
    https://doi.org/10.5806/AST.2021.34.5.212
    Rohankumar R. Chavan (Dept. of Pharmaceutical Chemistry, Bharati Vidyapeet College of Pharmacy)
    Somnath D. Bhinge (Dept. of Pharmaceutical Chemistry, Rajarambapu College of Pharmacy)
    Mangesh A. Bhutkar (Dept. of Pharmaceutics, Rajarambapu College of Pharmacy)
    Dheeraj S. Randive (Dept. of Pharmaceutics, Rajarambapu College of Pharmacy)
    Vijay R. Salunkhe (Dept. of Pharmacognosy, Rajarambapu College of Pharmacy)
    Rohankumar, R. C. , Somnath, D. B. , Mangesh, A. B. , Dheeraj, S. R. , & Vijay, R. S. (2021). . 분석과학, 34(5), 212-224, https://doi.org/10.5806/AST.2021.34.5.212
    • 다운로드 수
    • 조회수

    Abstract

    The intent of the present work was to develop a simple, sensitive, accurate, precise, rapid and economical UV- spectrophotometric and reverse phase high pressure liquid chromatographic method for the simultaneous estimation of Spironolactone and Furosemide in bulk and combined tablet dosage forms. UVSpectrophotometry was carried out by simultaneous equation method using 0.02 M potassium dihydrogen phosphate buffer pH 3.5: Acetonitrile (50:50) v/v as a solvent. The linearity range was 2-14 μg mL−1 for Spironolactone and Furosemide with a correlation coefficient > 0.99. The chromatographic separation was achieved on 250 mm × 4.6 mm, hypersil BDS C18 column with particle size 5 μm, by using an isocratic mixture of 0.02 M potassium dihydrogen phosphate buffer pH 3.5: Acetonitrile: tert butyl methyl ether (49:50:1) v/v/v as a solvent at a flow rate of 1 mL min−1 and UV detection was carried out at 254 nm. The retention time were observed to be 3.666 and 6.661 minutes for Furosemide and Spironolactone respectively. The two developed methods were validated according to the ICH guidelines for accuracy, precision, linearity, LOD, LOQ and were found to be within the limits. It can be concluded that these two methods could be successfully used for the simultaneous estimation of Spironolactone and Furosemide in bulk and combined tablet dosage forms.

    keywords
    UV-spectroscopic, RP-HPLC, spironolactone, furosemide


    참고문헌

    1

    1. G Giebisch, Arzneimittelforschung, 35(1A), 336-342(1985).

    2

    2. A. Qureshi and I. J. McGilveray, Drug Dev. Ind. Pharm., 24, 995-1005 (1998).

    3

    3. M. E. Bosch, A. J. R. Sánchez, F. S Rojas and C. B. Ojeda, Int. J. Pharm. Biol. Sci., 3, 168-181 (2013).

    4

    4. E. Dinç and Ö. Üstünda?, Farmaco, 58, 1151-1161(2003).

    5

    5. G. Kher, V. Ram, M. Kher and H. Joshi, Res. J. Pharm. Biol. Chem. Sci., 4, 365-377 (2013).

    6

    6. J. N. Tandel, Eura. J. Anal. Chem., 12, 385-394 (2017).

    7

    7. https://liverfellow.org/post/diuretics-ascites, Assessed 24July 2021.

    8

    8. I. Velat, Ž. Bušić, M. J. Paić and V. Čulić, BMC Pharmacol. Toxicol., 21, 57 (2020).

    9

    9. H. Patel and S. Solanki, Asian J. Pharm. Clin. Res., 5, 195-198 (2012).

    10

    10. S. Naveed, F. Qamar and S. Zainab, J. Innov. Pharm. Biol. Sci., 1, 97-101 (2014).

    11

    11. M. C. F. Ferraro, P. M. Castellano and T. S. Kaufman, J. Pharm. Biomed. Anal., 34, 305-314 (2004).

    12

    12. M. L. Luis, J. M. García, F. Jiménez, A. J. Jiménez and J. J. Arias, J. AOAC Int., 82, 1054-1063 (1999).

    13

    13. H. Patel and S. Solanki, Int. J. Pharm. Pharm. Sci., 4, 2-5 (2012).

    14

    14. M. A. Hegazy, F. H. Metwaly, M. Abdelkawy and N. S Abdelwahab, J. Chromatogr. Sci., 49, 129-135 (2011).

    15

    15. M. C. Ferraro, P. M. Castellano and T. S. Kaufman, J. Pharm. Biomed. Anal., 26, 443-451 (2001).

    16

    16. S. Chawla, S. Ghosh, V. Sihorkar, R. Nellore, T. R. S. Kumar and N. R. Srinivas, Biomed. Chromatogr., 20, 349-357 (2006).

    17

    17. N. Dubey, G. Patil, D. Kumar and J. Subhash, Int. J. Biomed. Pharm. Sci., 7, 38-41 (2013).

    18

    18. I. Youm and B. C. Youan, J. Anal. Meth. Chem., 2013, Article ID 207028 (2013).

    19

    19. R. Laxman, A. Ashish, J. Vinay, B. Sudhir and J. Deepti, Int. J. Res. Ayurveda Pharm., 1, 459-467 (2010).

    20

    20. J. M. Sandall, J. S. Millership, P. S. Collier and J. C. McElnay, J. Chromatogr. B Anal. Tech. Biomed. Life Sci., 839, 36-44 (2006).

    21

    21. S. S. Israt, M. N. Uddin, R. A. Jahan and M. M. Karim, Bangladesh J. Sci. Indust. Res., 51, 297-306 (2016).

    22

    22. M. Bhojani, K. Dadhania and S. Faldu, Journal of Pharmaceutical Science and Bioscientific Research, 2, 144-147 (2012).

    23

    23. A. S. S. V. Reddy, M. Ahmed and A. S. K. Ashetty, Int. J. ChemTech Res., 5, 1876-1885 (2013).

    24

    24. P. Parimoo, A. Bharathi and K. Padma, Indian J. Pharm. Sci., 57(3), 126-129 (1995).

    25

    25. J. Thriveni, R. Rambabu, J. V Rao and S. Vidyadhara, Int. J. Res. Pharm. Chem., 3, 208-212 (2013).

    26

    26. M. Bhojani, K. Ketan and F. Shital, J. Pharm. Sci. Biosci. Res., 2, 144-147 (2012).

    27

    27. V. R. Ram, P. N. Dave and H. S. Joshi, J. Chromatogr. Sci., 50, 721-726 (2012).

    28

    28. C. Vadloori and V. Tallada, J. Pharm. Res., 5(8), 3998-4000 (2012).

    29

    29. Q2A ICH guideline, Validation of analytical procedures text methodology, 2003.

    30

    30. S. D. Bhinge, S. M. Malipatil and L. V. Sonawane, Thai J. Pharm. Sci., 36, 63-71 (2012).

    31

    31. The United States Pharmacopoeia 35 National formulary

    32

    30. Eas-ton; R and Mc Nally Taunton; (2012).

    33

    32. Y. D. Dange, V. R. Salunkhe, S. D. Bhinge, B. R. Bhutkar and Y. H. Momin, Indian Drugs, 55, 61-66, (2017).

    34

    33. Y. D. Dange, S. M. Honmane, S. D. Bhinge, V. R. Salunkhe and D. R. Jadge, Indian J. Pharm. Edu. Res., 52, S46-S52 (2018).

    35

    34. S. D. Bhinge, S. M. Malipatil and L. V. Sonawane, Acta Chim. Slov., 61, 580-586 (2014).

    36

    35. S. D. Bhinge, S. M. Malipatil, A. Jondhale, R. Hirave and A. S. Savali, E-J. Chem., 9, 1223-1229 (2012).

    37

    36. S. D. Bhinge, S. M. Malipatil, A. Jondhale and A. S. Savali, Asian J. Chem., 25, 981-985 (2013).

    38

    37. http://ccc.chem.pitt.edu/wipf/Web/LCMS%20trouble%20shooting.pdf, Accessed on 11/06/2021.

    • 다운로드 수
    • 조회수
    • 0KCI 피인용수
    • 0WOS 피인용수

    권호 내 다른 논문

    추천 논문

    상단으로 이동

    권호 목록

    소개

    규정 및 지침

    게시판

    COPYRIGHT ⓒ - 한국분석과학회
    서울 마포구 마포대로 127;풍림VIP텔 1603호;(공덕동), +82-(0)2-701-8662
    proton@jbnu.ac.kr

      학술지 홈페이지 이용 환경은   크롬 브라우저 사용을 권장합니다.

    분석과학

    논문 투고 OA 정책